A case of chronic myeloid leukemia in a diagnostic radiographer
© Park et al.; licensee BioMed Central. 2014
Received: 1 September 2014
Accepted: 11 November 2014
Published: 28 November 2014
Occupational radiation exposure causes certain types of cancer, specifically hematopoietic diseases like leukemia. In Korea, radiation exposure is monitored and recorded by law, and guidelines for compensation of radiation-related diseases were implemented in 2001. However, thus far, no occupation-related disease was approved for compensation under these guidelines. Here, we report the first case of radiation-related disease approved by the compensation committee of the Korea Workers’ Compensation and Welfare Service, based on the probability of causation.
A 45-year-old man complained of chronic fatigue and myalgia for several days. He was diagnosed with chronic myeloid leukemia. The patient was a diagnostic radiographer at a diagnostic radiation department and was exposed to ionizing radiation for 21 years before chronic myeloid leukemia was diagnosed. His job involved taking simple radiographs, computed tomography scans, and measuring bone marrow density.
To our knowledge, this is the first approved case report using quantitative assessment of radiation. More approved cases are expected based on objective radiation exposure data and the probability of causation. We need to find a resolution to the ongoing demands for appropriate compensation and improvements to the environment at radiation workplaces.
The incidence rate of chronic myeloid leukemia (CML) is 1.5 per 100,000 people in the United States and 0.55 per 100,000 people in Korea . The incidence rate increases with age, specifically in those in their mid-40s and older. A known cause of CML is ionizing radiation and this correlation has been well characterized through studies on survivors of the Hiroshima nuclear bombing - and the Chernobyl accident . Other known risk factors for CML include age and smoking. The exposure to chemicals used in the rubber industry as well as X-rays, gamma rays, formaldehyde, and thorium-232 are also known occupational risk factors for CML .
Ionizing radiation is widely used in various fields in our society, such as diagnostic and therapeutic medicine, industry, and science. Ionizing radiation has the potential to produce radicals that are involved in DNA damage and gene translocation, which are among the initial steps of oncogenesis. The translocated gene in CML patients, i.e., the Philadelphia chromosome, is a diagnostic feature of CML. The Philadelphia chromosome produces a 210 kDa Bcr-Abl tyrosine kinase. This fusion protein strongly activates proliferating myeloid progenitor cells and confers resistance to apoptosis . Ionizing radiation is known to be one of the initiating factors of CML that leads to chromosome translocation. There are ongoing efforts to elucidate the initiating factors for CML.
Since 1996, in Korea, occupational radiation has been relatively well monitored and recorded by making it a legal requirement for all radiation workers to wear a thermoluminescence dosimeter (TLD). Furthermore, all radiation-related workplaces must report radiation exposure records from TLDs to the Ministry of Food and Drug Safety of Korea every three months . In spite of these preventive efforts, there have been many occupation-related diseases assumed to be caused by radiation exposure, but few cases have been compensated.
*RadRisk: Excess cancer risk due to radiation exposure, **BasRisk: Baseline cancer risk.
We report a case of CML in a diagnostic radiographer who had been exposed to radiation for over 20 years. To our knowledge, this is the first case that was approved by the compensation committee of Korea Workers’ Compensation and Welfare Service since the compensation guidelines based on PC were established.
Male patient aged 45 years at the time of diagnosis.
Chronic fatigue and pain in both shoulders and the lower back.
History of present illness
Chromosomal study (bone marrow) report
Study report (May 17, 2012)
MTX-synchronized high-resolution banding technique, GTG banding
Total number of cells examined
Total number of cells analyzed
The number of karyotypes
46, XY, t(9:22)(q34;q11.2)
CML with Philadelphia chromosome
The patient had never smoked and rarely drank alcohol.
Past medical history
The patient did not have hypertension, diabetes, tuberculosis, viral hepatitis, or human immunodeficiency virus infection.
There was no family history of hemato-oncologic diseases.
The patient’s occupational history
Nov, 1990 – Jan, 1991
Simple and special radiograph
Feb, 1991 – Dec, 2000
9 years and 11 months
Assistant at the nuclear medicine department
Jan, 2001 – Jul, 2002
1 year and 6 months
Simple and special radiograph, *CT
Sep, 2002 – May, 2012 (until diagnosed)
9 years and 6 months
Simple and special radiograph, Bone marrow density
Total 21 years and a month
The known one-time exposure amount of the various diagnostic tools
Average effective dose of radiation (mSv)*
Equivalent number of radiographs
Bonn isotope scintigraphy (99mTc-MDP)
CT coronary angiography
The patient’s work profile also included fixation and development of the exposed films. We investigated the chemicals used to fix and develop the film, but we found no known compound that could be considered to have initiated oncogenesis.
Evaluation of radiation
Accumulated radiation (in mSv) from 1997 to 2012
Radiation per quarter of a year
The patient mentioned that he was very stressed specifically from 2002 to 2006 because several cases of radiography had to be performed and there was no assistant to help with the workload. With regards to the missing records from 1990 to 1996, the patient estimated that the accumulated radiation would be comparable to that of 2003 to 2005, or even higher. Conventionally, younger workers tend to take more jobs than senior workers. Furthermore, the working environment then was worse than the present working conditions, and past radiologic shield methods were not as effective .
Probabilities of causation
Type of disease
Leukemia, except CLL*
Leukemia, except CLL
Generally, the PC is calculated to evaluate the extent of contribution of radiation exposure to the onset of cancer. It is legally noted that if a worker involved in a radiation-related job gets a certain type of solid tumor, and the PC is over 50% at the 50th percentile, then the worker would be compensated for the disease. However, in cases of leukemia, the patient is eligible to be compensated if the PC is over 33% at the 50th percentile . In this study, the patient’s PC was over 33% at the 50th percentile, in which the estimation for the missing records was 17.48 mSv, the highest estimation, and 6.02 mSv was the mean value for the most recent 16 years of radiation exposure.
This case report has certain limitations. Firstly, except for the period from 1990 to 1996, most of the radiation records were available. To obtain the best estimation of the radiation exposure during that period, we investigated the working environment thoroughly and conducted interviews with the patient and several of his co-workers. Since the PC was considerably over 33% at the 50th percentile in both assumptions, this case could be approved by the committee of the Korea Workers’ Compensation and Welfare Service. In spite of the approval, however, the patient’s PC was not fully based on the objective data. Secondly, the patient claimed that he wore a TLD throughout his work hours. There is, however, a slight possibility that he wore it in an inappropriate way or that he just did not wear the TLD. The TLD is a very useful equipment to monitor radiation exposure and, by law, all radiation workers must wear a TLD on their laboratory coat collar. After the enforcement of strict regulations for radiation workers, any worker with a TLD shown to be over the limit for a given period would be excluded from the job. Apart from this case report, some radiation workers who excused the occupation-related diseases insisted they had no choice but to not wear a TLD to maintain their jobs. Lastly, there are still other possible factors causing CML except radiation, and there can be other ways to evaluate radiation exposure. We consulted the Korea Hydro and Nuclear Power Company to find the most suitable calculation to date for this report; however, we cannot assume that radiation exposure is the only factor that triggers CML. Despite these limitations, there is a high likelihood that radiation triggered CML in this case.
According to the 2012 report of occupational exposure in diagnostic radiology, there were 62,935 radiation workers in Korea  and this number is increasing. Among workers who received a warning for exceeding their radiation quarter limits, diagnostic radiographers comprised the majority . In contrast to these reports, there were only a few compensated work-related diseases with regard to radiation exposure. The first case was acute myeloid leukemia in a nondestructive test worker in 1990, which was concluded by administrative jurisdiction. From 1996 to 2006, there were only 4 compensated cases caused by ionizing radiation , and all of them were evaluated by qualitative assessment without the PC calculation and compensation guidelines. The guidelines were still under development during that time period, and the PC program for Korea was initiated in 2004. The legal issues left no choice but to utilize qualitative assessment.
The PC program we utilized is called RHRI-PEPC, which was developed by the Korea Hydro and Nuclear Power Company. The baseline cancer incidence data were obtained from each province in Korea and were estimated using the International Agency for Research on Cancer classification of cancer. However, the PC calculation has certain limitations. The PC program sets the type of cancer and takes into account radiation doses. Theoretically, the organ dose should be used to estimate the PC, but there are certain limitations. Organ dose is estimated by the radiation distribution of uncertainty or using the radiation effectiveness factor ,. Furthermore, since the PC is a matter of probability, there should be incorporation of uncertainty into the calculation. In the United States, The National Institute for Occupational Safety and Health runs a PC calculation program called the Interactive Radio-Epidemiological Program to evaluate the individual’s radiation exposure, and the department of labor of the United States uses a 99% credibility limit of the PC in adjudication claims for compensation . However, except for workers in energy facilities or nuclear weapon facilities in the government, workers in the United States are not evaluated using 99% of the significance level. This policy is preferentially reserved for men of national merit, or veterans to compensate for their devotion to their country, and to avoid unnecessary legal issues. In contrast to the United States, we are still using the point estimation, but there are ongoing efforts to set the appropriate credibility limit . Based on the results of that study, 95% was suggested as an appropriate value after thorough consideration of future compensatory issues and the working environments of radiation workers in Korea. In addition to suggesting the screening dose based on the PC, they estimated the number of cases that could be approved with work-related disease for the next 10 years; there would be three to five, four to six, and six to ten cases under 90%, 95%, and 99% significance levels, respectively.
This case is the first one to be approved by the committee of compensation for work-related diseases. Based on the PC and objective exposure data, we expect more cases to be approved and the compensation guidelines to be reviewed and revised to incorporate uncertainty.
Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Chen Y, Wang H, Kantarjian H, Cortes J: Trends in chronic myeloid leukemia incidence and survival in the United States from 1975 to 2009. Leuk Lymphoma 2013, 54(7):1411–1417. 10.3109/10428194.2012.745525View ArticlePubMedGoogle Scholar
- Cardis E, Gilbert ES, Carpenter L, Howe G, Kato I, Armstrong BK, Beral V, Cowper G, Douglas A, Fix J, Fry SA, Kaldor J, Lave C, Salmon L, Smith PG, Volez GL, Wiggs LD: Effects of low doses and low dose rates of external ionizing radiation: cancer mortality among nuclear industry workers in three countries. Radiat Res 1995, 142(2):117–132. 10.2307/3579020View ArticlePubMedGoogle Scholar
- Preston DL, Kusumi S, Tomonaga M, Izumi S, Ron E, Kuramoto A, Kamada N, Dohy H, Matsuo T, Nonaka H, Thompson DE, Soda M, Mabuchi K: Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950–1987. Radiat Res 1994, 137: S68-S97. 10.2307/3578893View ArticlePubMedGoogle Scholar
- Pierce DA, Shimizu Y, Preston DL, Vaeth M, Mabuchi K: Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950–1990. Radiat Res 1996, 146: 1–27. 10.2307/3579391View ArticlePubMedGoogle Scholar
- Moysich KBMR, Michalek AM: Chernobyl-related ionising radiation exposure and cancer risk: an epidemiological review. Lancet 2002, 3: 269–279. 10.1016/S1470-2045(02)00727-1View ArticlePubMedGoogle Scholar
- Cogliano VJ, Baan R, Straif K, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Wild CP: Preventable exposures associated with human cancers. J Natl Cancer Inst 2011, 103(24):1827–1839. 10.1093/jnci/djr483View ArticlePubMedPubMed CentralGoogle Scholar
- Sawyers CL: Chronic myeloid leukemia. N Engl J Med 1999, 340(17):1330–1340. 10.1056/NEJM199904293401706View ArticlePubMedGoogle Scholar
- Nuclear safety and security commission of Korea: Regulation on the Evaluation and Management of Personal Radiation Exposure. Notification 2013–39.Google Scholar
- Lim HS, JY , Jeong MS, Lee BI, Cho DH, Oh JJ, Kim JI, Jeong C, Lee K: A Study of the Modification on Guidelines for Occupational Diseases Among Radiation Exposed Workers. 2004.Google Scholar
- Choi KH, Ha M, Lee WJ, Hwang SS, Jeong M, Jin YW, Kim HJ, Lee KY, Lee JE, Kang JW, Kim H: Cancer risk in diagnostic radiation workers in Korea from 1996–2002. Int J Environ Res Public Health 2013, 10(1):314–327. 10.3390/ijerph10010314View ArticlePubMedPubMed CentralGoogle Scholar
- Jeong MS, JY , Lim HS, Kim CS: Use of screening dose to evaluate the work-relatedness of cancers occurring among Korean radiation workers. Korean J Occup Envrin Med 2007, 3(19):196–203.Google Scholar
- Davies HE, Wathen CG, Gleeson FV: The risks of radiation exposure related to diagnostic imaging and how to minimise them. BMJ 2011, 342: d947. 10.1136/bmj.d947View ArticlePubMedGoogle Scholar
- Vaño E, Gonzalez L, Fernandez JM, Alfonso F, Macaya C: Occupational radiation doses in interventional cardiology: a 15-year follow-up. Br J Radiol 2006, 79(941):383–388. 10.1259/bjr/26829723View ArticlePubMedGoogle Scholar
- Meeseon Jeong Y-W, Kim CS: Program for estimating the probability of causation to Korean radiation workers with cancer. J Korea Asso Radiat Prot 2004, 29(4):221–230.Google Scholar
- Korea Centers for Disease Control and Prevention Division of Health & Nutrition survey Medical Radiation T/F: 2012 report occupational exposure in diagnostic radiology. Report of Korean Center for Disease Control and National Dose Registry of Korea, 2013:1–40Google Scholar
- E-a K: Occupational diseases of health care workers. Hanyang Med Rev 2010, 30(4):265–273. 10.7599/hmr.2010.30.4.265View ArticleGoogle Scholar
- Ahn YS: Occupational malignant lymphohematopoietic diseases compensated under the industrial accident compensation insurance from 1996 to 2005. Korean J Occup Environ Med 2007, 19(2):81–92.Google Scholar
- Kocher DC, Apostoaei AI, Henshaw RW, Hoffman FO, Schubauer-Berigan MK, Stancescu DO, Thomas BA, Trabalka JR, Gilbert ES, Land CE: Interactive RadioEpidemiological Program (IREP): a web-based tool for estimating probability of causation/assigned share of radiogenic cancers. Health Phys 2008, 95(1):119–147. 10.1097/01.HP.0000291191.49583.f7View ArticlePubMedPubMed CentralGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.